Nepipe (Epinephrine)

Epinephrine works by non‑selectively stimulating alpha and beta adrenergic receptors. Alpha‑1 activation causes vasoconstriction, raising blood pressure; beta‑1 activation boosts heart rate and contractility; beta‑2 activation relaxes bronchial smooth muscle and reduces mediator release from mast cells, counteracting allergic responses.

The dose of Nepipe is determined by the prescribing clinician based on the patient’s age, weight, severity of the reaction, and clinical guidelines. Healthcare professionals calculate the appropriate amount and route at the point of care.

Safety data for epinephrine in pregnancy and lactation are limited. It should be used only when clearly needed and when the potential benefit outweighs any possible risk to the fetus or infant. The prescriber will evaluate each case individually.

To order Nepipe, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Compared with other adrenergic agents such as norepinephrine, epinephrine provides both alpha‑ and beta‑mediated effects, making it uniquely effective for simultaneous vasoconstriction, cardiac stimulation, and bronchodilation. This broad activity profile is why it is the first‑line choice for anaphylaxis and cardiac arrest, whereas other agents may target only one receptor type.

Nepipe should be stored below 25 °C, in its original container, protected from light and moisture. Do not freeze the product. Before use, inspect the vial for particulate matter or discoloration and handle with clean gloves to maintain sterility.

Nepipe is given by intramuscular injection, typically into the anterolateral thigh. The injection site should be cleaned with an alcohol swab, and the needle inserted at a 90‑degree angle to ensure proper intramuscular delivery. Rapid administration is essential in emergency situations.

Serious risks include hypertensive crisis, life‑threatening cardiac arrhythmias, myocardial ischemia, pulmonary edema, and paradoxical severe bronchospasm. Immediate monitoring of blood pressure, heart rhythm and respiratory status is required after administration to detect these complications early.

Contraindications include patients with known hypersensitivity to epinephrine or any formulation component, and those with certain cardiovascular conditions such as uncontrolled hypertension, recent myocardial infarction, or severe arrhythmias unless the clinical benefit justifies use. The prescriber must evaluate each patient’s medical history.